According to Sonoma Pharmaceuticals latest financial reports the company has an operating margin of -0.34%, an decrease of -26.14% to 2022. At the end of 2022 company had an operating margin of -0.47%.
Year | Operating Margin | Change |
---|---|---|
2023 | -0.34% | -26.14% |
2022 | -0.47% | 151.80% |
2021 | -0.19% | -55.09% |
2020 | -0.41% | - |